Antibodies for HIV prevention: the path forward
J Int AIDS Soc
.
2023 May;26(5):e26097.
doi: 10.1002/jia2.26097.
Authors
Shelly Malhotra
1
,
Rachel Baggaley
2
,
Sharonann Lynch
3
,
Carmen Pérez-Casas
4
,
Yvette Raphael
5
,
Lynda Stranix-Chibanda
6
Affiliations
1
IAVI, New York, USA.
2
World Health Organization, Geneva, Switzerland.
3
O'Neill Institute, Georgetown University, Washington, DC, USA.
4
Unitaid, Geneva, Switzerland.
5
Advocacy for the Prevention of HIV in Africa, Johannesburg, South Africa.
6
Harare Health and Research Consortium, Harare, Zimbabwe.
PMID:
37195217
PMCID:
PMC10191127
DOI:
10.1002/jia2.26097
No abstract available
MeSH terms
Antibodies, Neutralizing
HIV Antibodies
HIV Infections* / epidemiology
HIV Infections* / prevention & control
HIV-1*
Humans
Substances
Antibodies, Neutralizing
HIV Antibodies
Grants and funding
001/WHO_/World Health Organization/International